Global Cystic Fibrosis Therapeutics Market to Grow at a CAGR of 31.9% During the Period 2016 - 2020; Finds New Report
Report forecast the global cystic fibrosis therapeutics market to grow at a CAGR of 31.9% during the period 2016-2020. Cystic fibrosis, also known as mucoviscidosis, is a genetically inherited, chronic disease and is progressive in nature. The onset of cystic fibrosis typically occurs in early childhood or, rarely, at birth. The primary symptoms of cystic fibrosis include breathing difficulties, high salt content in the sweat, and secretion of abnormally viscous mucus.
View full press release